Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8820085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model.

  1995cited by this paper
• Posttransplant coronary artery disease in children. A multicenter national survey.

  1994cited by this paper
• Cardiac transplantation: the Stanford experience in the cyclosporine era.

  1994cited by this paper
• Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• A new rat infection-heart transplant model: effect of infection on graft survival studies.

  1993cited by this paper
• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cited by this paper
• A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.

  1993cited by this paper
• Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.

  1992cited by this paper
• Transplant coronary artery disease.

  1992cited by this paper
• Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.

  1992cited by this paper
• Histopathology of graft coronary disease.

  1992cited by this paper
• Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.

  1992cited by this paper
• Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs.

  1992cited by this paper
• Transplant coronary artery disease: histopathologic correlations with angiographic morphology.

  1991cited by this paper
• Expression of platelet-derived growth factor receptor in rat heart allografts.

  1991cited by this paper
• Calcium Antagonists and Atherosclerosis

  1991cited by this paper
• Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue.

  1990cited by this paper
• Potassium-39 nuclear magnetic resonance observation of intracellular potassium without chemical shift reagents during metabolic inhibition in the isolated perfused rat heart.

  1990cited by this paper
• Rapidly proliferative arteriopathy in cyclosporin‐induced permanently surviving rat cardiac allografts simulating chronic vascular rejection

  1990cited by this paper
• Role of smooth-muscle cells and macrophages in cardiac allograft arteriosclerosis in rabbits.

  1990cited by this paper
• Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

  1990cited by this paper
• Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide.

  1989cited by this paper
• Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis.

  1989cited by this paper
• Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil.

  1989cited by this paper
• THALLIUM KINETICS IN RAT CARDIAC TRANSPLANT REJECTION

  1988cited by this paper
• Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.

  1988cited by this paper
• Responses of coronary arteries of cardiac transplant patients to acetylcholine.

  1988cited by this paper
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

  1987cited by this paper
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

  1987cited by this paper
• Antiatherogenic properties of calcium antagonists.

  1987cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• Suppression of Atherosclerosis in Cholesterol‐Fed Rabbits by Diltiazem Injection

  1986cited by this paper
• Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.

  1986cited by this paper
• Role of endothelium in responses of vascular smooth muscle.

  1983cited by this paper
• PATHOGENESIS AND PREVENTION OF GRAFT ARTERIOSCLEROSIS IN AN EXPERIMENTAL HEART TRANSPLANT MODEL

  1981cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Optimal medical therapy to improve saphenous vein graft patency

  2017cites this paper
• Current therapies for cardiac allograft vasculopathy in children.

  2012cites this paper
• Cardiac allograft vasculopathy: recent developments.

  2008cites this paper
• Endothelial dysfunction and accelerated coronary artery disease in cardiac transplant recipients

  2005cites this paper
• The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.

  2005cites this paper
• THE NEW ZEALAND MEDICAL JOURNAL 12 November 1999 Volume 112 No 1099 EDITORIALS The Journal : into the new millennium

  2005cites this paper
• 2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation.

  2003cites this paper
• Immunology of pediatric heart transplantation: a clinical update.

  2001cites this paper
• Transplant coronary artery disease in children.

  2000cites this paper
• Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathy.

  2000cites this paper
• Cardiac allograft vasculopathy: the green lane hospital experience 1987-1998.

  1999cites this paper
• Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts.

  1999cites this paper
• Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts.

  1999cites this paper
• Microvascular Endothelial Dysfunction after Heart Transplantation

  1999cites this paper
• Endothelial dysfunction and accelerated coronary artery disease in cardiac transplant recipients. Microcirculation Working Group, European Society of Cardiology.

  1997cites this paper
• Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.

  1997cites this paper
• Cardiac allograft vasculopathy: a review.

  1997cites this paper